Optimized Reversed-Phase Liquid Chromatography/Mass Spectrometry Methods for Intact Protein Analysis and Peptide Mapping of Adeno-Associated Virus Proteins-Reference-Cited by-同舟云学术

Optimized Reversed-Phase Liquid Chromatography/Mass Spectrometry Methods for Intact Protein Analysis and Peptide Mapping of Adeno-Associated Virus Proteins

Published:2021-12-01 Issue:23-24 Volume:32 Page:1501-1511
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Zhang Ximo¹^ORCID,Jin Xiaoying²,Liu Lin²,Zhang Zichuan²,Koza Stephan¹,Yu Ying Qing¹,Chen Weibin¹

Affiliation:

1. Scientific Operations, Waters Corporation, Milford, Massachusetts, USA.

2. Global CMC Development, Sanofi, Framingham, Massachusetts, USA.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/hum.2021.046

Reference28 articles.

1. Gene therapy comes of age

2. Engineering adeno-associated virus vectors for gene therapy

3. Engineered Capsids for Efficient Gene Delivery to the Retina and Cornea

4. Structure and Dynamics of Adeno-Associated Virus Serotype 1 VP1-Unique N-Terminal Domain and Its Role in Capsid Trafficking

5. Structural Proteins of Adenovirus-Associated Viruses

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of AAV vectors: A review of analytical techniques and critical quality attributes;Molecular Therapy - Methods & Clinical Development;2024-09

2. Advances in analytical technologies for emerging drug modalities and their separation challenges in LC-MS systems;Journal of Chromatography A;2024-09

3. Advances and opportunities in process analytical technologies for viral vector manufacturing;Biotechnology Advances;2024-09

4. Assessment of adeno-associated virus purity by capillary electrophoresis-based western;Molecular Therapy - Methods & Clinical Development;2024-09

5. Production of recombinant adeno-associated virus 5 using a novel self-attenuating adenovirus production platform;Molecular Therapy - Methods & Clinical Development;2024-09